First new antibiotic for UTIs in 20 years approved to help millions of women ... trends now

First new antibiotic for UTIs in 20 years approved to help millions of women ... trends now
First new antibiotic for UTIs in 20 years approved to help millions of women ... trends now

First new antibiotic for UTIs in 20 years approved to help millions of women ... trends now

The FDA has  approved the drug pivmecillinam for 'uncomplicated' UTIs It will be sold under the brand name Pivya in America from sometime in 2025 READ MORE: Victims of a 'killer' antibiotic: Mother, 44, suffers stroke

View
comments

For the first time in two decades, a new pill for urinary tract infections has been approved in hopes of combating bugs that are resistant to antibiotics.

The FDA has approved the drug pivmecillinam - sold under the brand name Pivya - for 'uncomplicated' UTIs, meaning the infection is contained within the bladder and has not spread to the kidneys.

It has been used as a first-line treatment in Europe for over 40 years but will become available on prescription to millions of US women over the age of 18 next year.

Utility Therapeutics, the company developing the drug, is also seeking approval for a intravenous version given in the hospital for more serious infections.

The FDA has approved the drug pivmecillinam - sold as Pivya in the US - for 'uncomplicated' UTIs, meaning the infection is contained within the bladder and has not spread to the kidneys

The FDA has approved the drug pivmecillinam - sold as Pivya in the US - for 'uncomplicated' UTIs, meaning the infection is contained within the bladder and has not spread to the kidneys

'Uncomplicated UTIs are a very common condition impacting women and one of the most frequent reasons for antibiotic use,' said Dr Peter Kim, director of the Division of Anti-Infectives in the FDA's Center for Drug Evaluation and Research.

'The FDA is committed to fostering new antibiotic availability when they prove to be safe and effective.' 

It is the first time in 20 years that the FDA has approved a new

read more from dailymail.....

NEXT UK's prostate cancer revolution: 'Biggest trial in a generation' could lead to ... trends now